Risk of thromboembolic events after protocolized warfarin reversal with 3-factor PCC and factor VIIa by Barton, Cassie A., PharmD, BCPS, Johnson, Nathan B., PharmD, Case, Jon, PharmD, BCPS, Warden, Bruce, PharmD, BCPS, Hughes, Darrel, PharmD, BCPS, Zimmerman, Jason, PharmD, Roberti, Gregory, PharmD, BCPS, BCNSP, McMillian, Wesley D., PharmD, BCPS, Schreiber, Martin, MD

Get full text